Ionis Pharmaceuticals | Los Gastos Financieros De La Deuda



Interest Expense On Debt Cambio Fecha
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 40.25M 1.6M 2025-06
Arrowhead Research USD 24.38M 2.74M 2025-06
Astellas Pharma 3.91B 320M 2025-03
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Celltrion KRW 17.04B 1.34B 2025-03
Cspc Pharmaceutical 10.38M 934K 2024-12
Divis Laboratories Ltd 30M 20M 2025-06
Exelixis 23.4M 3.9M 2023-09
Halozyme Therapeutics USD 4.39M 131K 2025-06
Ionis Pharmaceuticals USD 19M 0 2025-06
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Medical Developments International AUD 21K 23K 2024-06
Moderna USD 1000K 0 2025-06
Neuren Pharmaceuticals 0 0 2024-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 289M 19M 2025-06
OPKO Health USD 17.36M 9.88M 2024-09
Pfizer USD 654M 0 2025-06
PTC Therapeutics USD 30.36M 4.03M 2025-06
Qiagen NV USD 7.6M 311K 2025-06
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 5.23M 725K 2025-06
Sartorius 41.4M 51.4M 2025-06
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tilray USD 7.77M 2.08M 2024-11
Ultragenyx Pharmaceutical 14.04M 1.48M 2025-06
Vertex Pharmaceuticals USD 3.7M 900K 2025-06
Zz Pientze Pharmaceu 9.17M 60K 2024-09


Ionis Pharmaceuticals Los Gastos Financieros De La Deuda - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.